View By Professional Interest Track

            Collaborative       Nurse       Practice Management       Psychology       TWP (Begins Nov. 1)
Rakesh Jain, MD, MPH
Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas

Sunday, November 1 04:45 -05:15 p.m.
TWP 130.0 - Panel Question and Answer Session
- Room: Lagoon Ballroom
Vladimir Maletic, MD, PA, Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University
Charles Raison, MD, Associate Professor Clinical Director Mind-Body Program Department of Psychiatry and Behavioral Sciences Emory University School of Medicine Atlanta, GA
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas
Jon Draud, MD, MS, Private Practice, Psychopharmacology and Adult Psychiatry, Heritage Medical Associates, PC; Medical Director, Psychiatry and Addiction Medicine Services, Baptist Hospital; Clinical Professor, Department of Psychology Vanderbilt University, Nashville, TN

Join the entire faculty of Treating the Whole Patient for an Extended Question and Answer session at the end of Day 1.

Monday, November 2 10:55- 12:00 p.m.
TWP 210.0 - Understanding Mind-Body Disorder Treatment Paradigms, Part I
1 credits - Room: Lagoon Ballroom
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas

Emerging evidence compels us to take a fresh look at the treatment of depression. Quite forcefully, data directs us to view depression as a mind-body disorder. As a result, today's clinicians need to expand their treatment paradigms to be inclusive of  mind-body disruptions (not one or the other, but both). This section of the comprehensive mind-body presentation examines treatment data in detail, and offers clinicians cutting edge tools and paradigms to achieve optimum outcomes as they treat patients afflicted with depression.

Upon the completion of this activity, participants will be able to:

  1. Recognize the importance of full symptomatic and functional recovery.
  2. Identify the relationship of inflammation, stress and mood disorders (ie, the neurobiological correlates).
  3. Discuss the significance of the biological, psychosocial, and nonpharmacological treatment options in the treatment of depression.
Monday, November 2 12:45-1:30 p.m.
TWP 220.0 - Understanding Mind-Body Disorder Treatment Paradigms, Part 2
1.5 (With Q&A) credits - Room: Lagoon Ballroom
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas

Emerging evidence compels us to take a fresh look at the treatment of depression. Quite forcefully, data directs us to view depression as a mind-body disorder. As a result, today's clinicians need to expand their treatment paradigms to be inclusive of  mind-body disruptions (not one or the other, but both). This section of the comprehensive mind-body presentation examines treatment data in detail, and offers clinicians cutting edge tools and paradigms to achieve optimum outcomes as they treat patients afflicted with depression.

Upon the completion of this activity, participants will be able to:

  1. Recognize the importance of full symptomatic and functional recovery.
  2. Identify the relationship of inflammation, stress and mood disorders (ie, the neurobiological correlates).
  3. Discuss the significance of the biological, psychosocial, and nonpharmacological treatment options in the treatment of depression.
Monday, November 2 01:30-2:25 p.m.
TWP 230.0 - Panel Question and Answer Session
- Room: Lagoon Ballroom
Vladimir Maletic, MD, PA, Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University
Charles Raison, MD, Associate Professor Clinical Director Mind-Body Program Department of Psychiatry and Behavioral Sciences Emory University School of Medicine Atlanta, GA
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas
Jon Draud, MD, MS, Private Practice, Psychopharmacology and Adult Psychiatry, Heritage Medical Associates, PC; Medical Director, Psychiatry and Addiction Medicine Services, Baptist Hospital; Clinical Professor, Department of Psychology Vanderbilt University, Nashville, TN

Join the entire faculty of Treating the Whole Patient for an Extended Question and Answer session at the end of Day 2.

Tuesday, November 3 12:15-2:15 p.m.
270 - Depression and Pain: Advances in Neurobiology and Treatment I PD RX
1.5 credits - Room: Mandalay Bay Ballroom GH
Vladimir Maletic, MD, PA, Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas

The session will provide participants with strategies for improving the management of comorbid depression as well as chronic pain and other physical symptoms.

12:15PM-12:45 p.m. Lunch
12:45-2:15 p.m. Symposium

This activity is supported by an educational grant from Eli Lilly and Company.

This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC. The Institute for Continuing Healthcare Education is the content provider.

Tuesday, November 3 05:45- 07:00 p.m.
266 - Expanding Our Clinician's Treasure Chest - Creating a Toolkit of Screeners and Rating Instruments PD PI
1.25 credits - Room: Mandalay Ballroom KL
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas
Saundra Jain, PsyD, LPC, MBA, Executive Director, Mental Health Educational Initiative, Lake Jackson, Texas

Both psychiatric and nonpsychiatric clinicians tend to underutilize screeners and rating instruments in their busy practices. This is an error worth rectifying expeditiously for the following reasons: use of screeners and rating instruments can actually improve outcomes, it can be very time efficient and many quality tools are available for no charge. This workshop will show videos of a few clinical scenarios and discuss what tools might have been appropriate to use. Copies of noncopyrighted screeners and rating instruments, appropriate for both psychiatric and nonpsychiatric settings, will be made available to participants. A toolkit filled of screeners and rating instruments will be brought to the workshop to show participants how they can create one for their own use.

By participating in this activity, attendees will be able to:

  1. Recognize the many noncopyrighted tools available for clinician use covering a range of psychiatric disorders;
  2. Define these tools that are very time efficient and improve diagnostic yield; and
  3. Describe how to choose the right tool and how to score them.
Wednesday, November 4 02:30-03:45 p.m.
334 - Expanding Our Clinician's Treasure Chest - Creating a Toolkit of Screeners and Rating Instruments PI
1.25 credits - Room: Breakers EFKL
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas
Saundra Jain, PsyD, LPC, MBA, Executive Director, Mental Health Educational Initiative, Lake Jackson, Texas

Both psychiatric and nonpsychiatric clinicians tend to underutilize screeners and rating instruments in their busy practices. This is an error worth rectifying expeditiously for the following reasons: use of screeners and rating instruments can actually improve outcomes, it can be very time efficient and many quality tools are available for no charge. This workshop will show videos of a few clinical scenarios and discuss what tools might have been appropriate to use. Copies of noncopyrighted screeners and rating instruments, appropriate for both psychiatric and nonpsychiatric settings, will be made available to participants. A toolkit filled of screeners and rating instruments will be brought to the workshop to show participants how they can create one for their own use.

By participating in this activity, attendees will be able to:

  1. Recognize the many noncopyrighted tools available for clinician use covering a range of psychiatric disorders;
  2. Define these tools that are very time efficient and improve diagnostic yield; and
  3. Describe how to choose the right tool and how to score them.
Wednesday, November 4 04:00-05:15 p.m.
347 - Meditation, Inflammation and Consternation: Applying Ancient Wisdom to Mental Health in the Modern World PD CAM
1.25 credits - Room: Breakers EFKL
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas
Satya Dev Negi, MA, PhD, President, Director, Teacher and DLM Representative, Drepung Loseling Institute, Atlanta, GA Senior Lecturer, Department of Religion, Emory University
Charles Raison, MD, Associate Professor Clinical Director Mind-Body Program Department of Psychiatry and Behavioral Sciences Emory University School of Medicine Atlanta, GA

This is meditation's moment. From the cover of Time Magazine to the coffee table discussions of morning talk shows, meditation has acquired near mythic status both as an avenue to personal fulfillment and as a universal solvent against a dizzying array of diseases, mental and physical. However, despite increasing evidence that meditation may confer health benefits, significant gaps remain in our understanding of how meditation alters mind-body functioning to promote emotional and physical well-being. By providing a state-of-the-art update on what we do and do not know about meditation and meditation and mental health - with a focus on depression - this presentation will provide clinicians with information essential for thinking about how to incorporate meditation into their work with patients. The first talk in this program will provide an overview of research findings regarding mental health benefits of meditation, with a focus on rigorously examining areas of remaining uncertainty. The second talk will drill down deeper into a particular style of meditation - compassion meditation - to explore how this type of meditation may modulate deleterious stress responses relevant to health. The program will conclude with a chance for audience members to get a first hand sense of compassion meditation through a brief guided meditation.

At the end of this program, participants should be able to:

  1. Describe the most important unanswered research questions regarding how to best apply meditation to mental illness.
  2. Describe the different types of meditation practices that appear to offer the most promise as health interventions.
  3. Describe how meditation practices may improve central nervous system, stress and immune functioning in ways likely to benefit mental and physical disease.
  4. Describe what is known from the research literature regarding the effect of meditation on depression and anxiety in medically healthy and medically ill individuals.
  5. Describe strategies for implementing meditation into clinical practice.
Thursday, November 5 10:45-12:00 p.m.
437 - Motion in Emotion: Science and Art of Bringing Physical Exercise into your Treatment Plan PD CAM
1.25 credits - Room: Mandalay Bay Ballroom CD
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas
Charles Raison, MD, Associate Professor Clinical Director Mind-Body Program Department of Psychiatry and Behavioral Sciences Emory University School of Medicine Atlanta, GA

Does "Motion', that is, exercise have a place in our treatment armamentarium? This is a question all clinicians have frequently asked of themselves. The last decade of clinical and animal research has revealed surprising powerful positive effects of exercise on mood disorders. We now know that exercise affects brain volume, inflammatory cytokines, and the autonomic system. Clinical research data also points to exercise's powerful anti-depressant effects. In light of these exciting findings, this seminar is aimed at providing clinicians the research findings, as will as provide attendees with tools on how to "prescribe" exercise to their patients. Clinicians will be provided with tools to assist them in implementing an exercise prescribing program in their practices.

Upon the completion of the this activity, participants will be able to:

  1. Develop an scientifically and data based appreciation of the complex neurobiology of exercise's positive effects on  on mood.
  2. Examine the clinical, randomized data of exercise treatment in mood disorder and develop practical skills in applying this information to clinical care of patients.

  Terms of Service     Privacy     Advertising
  ©2009 CME LLC